Abstract-We previously identified an ␣1-AR-ERK (␣1A-adrenergic receptor-extracellular signal-regulated kinase) survival signaling pathway in adult cardiac myocytes. Here, we investigated localization of ␣1-AR subtypes (␣1A and ␣1B) and how their localization influences ␣1-AR signaling in cardiac myocytes. Using binding assays on myocyte subcellular fractions or a fluorescent ␣1-AR antagonist, we localized endogenous ␣1-ARs to the nucleus in wild-type adult cardiac myocytes. To clarify ␣1 subtype localization, we reconstituted ␣1 signaling in cultured ␣1A-and ␣1B-AR double knockout cardiac myocytes using ␣1-AR-green fluorescent protein (GFP) fusion proteins. Similar to endogenous ␣1-ARs and ␣1A-and ␣1B-GFP colocalized with LAP2 at the nuclear membrane. ␣1-AR nuclear localization was confirmed in vivo using ␣1-AR-GFP transgenic mice. The ␣1-signaling partners G␣q and phospholipase C␤1 also colocalized with ␣1-ARs only at the nuclear membrane. Furthermore, we observed rapid catecholamine uptake mediated by norepinephrine-uptake-2 and found that ␣1-mediated activation of ERK was not inhibited by a membrane impermeant ␣1-blocker, suggesting ␣1 signaling is initiated at the nucleus. Contrary to prior studies, we did not observe ␣1-AR localization to caveolae, but we found that ␣1-AR signaling initiated at the nucleus led to activated ERK localized to caveolae. In summary, our results show that nuclear ␣1-ARs transduce signals to caveolae at the plasma membrane in cardiac myocytes. (Circ Res. 2008;103:992-1000.)
C ardiovascular disease is the leading killer in the United
States, accounting for 1.4 million deaths a year. Five million Americans experience heart failure, leading to 970 000 hospitalizations annually, a number that has tripled in the last 25 years. 1 In heart failure, increased activation of the sympathetic nervous system is correlated with pathophysiologic remodeling of the heart, 2 which has led to the therapeutic use of ␤-adrenergic receptor (AR) antagonists in heart failure. However, the general conclusion that inhibition of catecholamine activation of ARs is beneficial in heart failure is disputed by clinical trials with ␣1-AR antagonists. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) demonstrated that the ␣1-antagonist doxazosin increased the risk of heart failure by 80% and stroke by 26% leading to termination of the trial. 3, 4 Similar detrimental effects were seen in the VasodilatorHeart Failure Trials (V-HeFT), in which prazosin was compared with other vasodilators for the prevention of death in heart failure. 5 All 3 ␣1-AR subtypes (A, B, and D) are expressed in the heart 6 -9 ; however, cardiac myocytes only express the ␣1A and ␣1B. 9 Using ␣1A-and ␣1B-AR double knockout mice (␣1ABKO), we demonstrated previously that ␣1-ARs are required for postnatal hypertrophy and adaptation to pathological stress. 9, 10 In ␣1ABKO mice, we found that aortic constriction induced dilated cardiomyopathy that led to heart failure and death. 9 More recently, we identified an ␣1A-AR-ERK (␣1A-AR-extracellular signal-regulated kinase) survival signaling pathway in adult cardiac myocytes, 11 and knockout of this ␣1A-ERK pathway could explain the maladaptive response to aortic constriction in ␣1ABKO mice. In summary, our data demonstrate that ␣1-ARs are protective in the heart, which agrees with clinical trials where ␣1-antagonists increased the incidence of heart failure.
Here, we examined the mechanisms of ␣1-AR survival signaling and expanded on our previous demonstration of ␣1-AR localization to the nucleus in adult cardiac myocytes. 11 To circumvent the lack of ␣1-AR subtype-specific antibodies and ligands, we developed a reconstitution system by expressing ␣1-AR-GFP (␣1-AR-green fluorescent protein) fusion proteins in cultured ␣1ABKO cardiac myocytes to examine ␣1-AR localization and survival signaling. With no endogenous ␣1-ARs, ␣1ABKO cardiac myocytes provide the ideal model for localization and signaling experiments. Earlier work in the mouse heart suggests that ␣1-ARs localize to the plasma membrane, possibly in caveolae and that ␣1-AR signaling can be modified by caveolin-3. [12] [13] [14] [15] These findings fit the classic "outside-in" model of G proteincoupled receptor (GPCR) localization and signaling because the immediate signaling partners (G␣q and phospholipase [PL]C␤1) are also localized to caveolae. 16, 17 In contrast, our previous data using ␣1-AR-GFP fluorescent fusion proteins suggested a nuclear localization for ␣1-ARs in adult cardiac myocytes. 11 Our identification of a GPCR (␣1-AR) localized to the nucleus is not without precedence. Recently, functional endothelin-A, endothelin-B and ␤-ARs were identified on the nucleus in adult cardiac myocytes. 18, 19 Using our reconstitution system, we set out to clarify ␣1-AR localization and study the mechanisms behind ␣1-AR-ERK survival signaling in adult cardiac myocytes. In this report, we found that endogenous ␣1-ARs localized to the nucleus in wild-type (WT) adult mouse cardiac myocytes, which was confirmed in vivo using a cardiacspecific ␣1-AR transgenic mouse. Confocal microscopy and cellular fractionation demonstrated that the ␣1-AR subtypes, G␣q, and PLC␤1 localized to the nuclear membrane in adult cardiac myocytes. Furthermore, we found no evidence that either ␣1-AR subtype localized to the plasma membrane or caveolae. Finally, activation of functional ␣1-ARs on the nucleus led to accumulation of activated (phosphorylated) ERK in caveolae at the plasma membrane. Our results present a provocative new model by demonstrating that ␣1-AR signaling initiated at the nucleus results in activated ERK localization in caveolae at the plasma membrane.
Materials and Methods
The procedures for generating adenoviral constructs, 11 culture of adult mouse cardiac myocytes, 10,11 localization of ␣1-ARs by confocal microscopy, 11 isolation 18, 19 and enrichment 20 of nuclei, and measurement of ␣1-AR expression 9 have been described elsewhere. Methods describing the generation of ␣1-AR-GFP transgenic mice, catecholamine uptake assay, treatment of cardiac myocytes with CGP-12177A, and detection of the extraneuronal monoamine transporter (EMT/OCT3) are available in the expanded Materials and Methods section of the online data supplement at http://circres. ahajournals.org. The use of animals in this study conformed to the Public Health Service Guide for Care and Use of Laboratory Animals and was approved by The University of South Dakota Institutional Animal Care and Use Committee.
Results

Endogenous ␣1-Adrenergic Receptors Localize to the Nucleus in WT Adult Mouse Cardiac Myocytes
Here, we set out to determine ␣1-AR subtype localization in adult cardiac myocytes. To examine ␣1-AR subcellular distribution, we isolated membrane, cytosolic, and nuclear fractions from freshly isolated WT adult mouse cardiac myocytes and measured ␣1-AR binding with 3 H-prazosin. Membrane, cytosolic, and nuclear fractions were validated by Western blots for caveolin-3, GAPDH, and LAP2, respectively ( Figure 1a ). Binding assays with 3 H-prazosin indicated that 80% of total ␣1-AR binding was detected in the nuclear fraction. Binding detected in the membrane fraction was likely a result of ␣1-ARs localized to endoplasmic reticulum, because SERCA2 was detected in the membrane fraction (Figure 1a ). To verify this finding, we examined endogenous ␣1-AR localization in cultured WT adult cardiac myocytes by labeling ␣1-ARs with a fluorescent, subtype-nonselective ␣1-AR antagonist, BODIPY-prazosin, which overcomes the lack of subtypespecific ␣1-AR antibodies. BODIPY-prazosin labeling revealed that endogenous ␣1-ARs were concentrated around the nucleus but not on the plasma membrane in WT cardiac myocytes (Figure 1b) . To verify that ␣1-ARs were expressed on the nucleus in cardiac myocytes, isolated nuclei from WT adult cardiac myocytes were also labeled with BODIPY-prazosin, and a strong signal was detected on the nuclear membrane (Figure 1b, insets) . In summary, these data suggest that endogenous ␣1-ARs localize primarily to the nucleus in WT adult cardiac myocytes.
The ␣1A and ␣1B Subtypes Colocalize With the Nuclear Membrane Protein LAP2 in Adult Mouse Cardiac Myocytes
To test whether the ␣1A and ␣1B subtypes localize to the nucleus, we assessed colocalization of both ␣1 subtypes with the inner nuclear matrix protein LAP2. Again, to overcome the lack of subtype-specific antibodies, we expressed ␣1-fluorescent fusion proteins (␣1-GFP) in cultured ␣1ABKO adult cardiac myocytes, which lack endogenous ␣1-ARs. 11 In this reconstitution system, the ␣1-GFP fusion proteins are expressed at only 2.5-to 3-fold over endogenous ␣1-AR levels. 11 Confocal microscopy revealed an intense GFP signal for both the ␣1A and ␣1B and, as expected, an intense fluorescent signal (red) for LAP2 on the nuclear membrane (Figure 2a) . Using Imaris image analysis software, we demonstrated that both ␣1 subtypes colocalize with the nuclear matrix protein LAP2 (Figure 2a, yellow) .
To confirm the confocal microscopy results, cellular fractions were isolated from cultured ␣1ABKO adult cardiac myocytes expressing the ␣1-GFP fusion proteins. Membrane, cytosolic, and nuclear fractions were validated by Western blots for caveolin-3, GAPDH, and LAP2, respectively ( Figure 2b ). As expected, both the ␣1A-GFP and ␣1B-GFP were detected predominantly in the isolated nuclear fraction (Figure 2b ). In summary, the results obtained in our reconstitution system by confocal microscopy and subcellular fractionation demonstrated that the ␣1A and ␣1B subtypes were expressed in the nuclear membrane and confirmed the nuclear localization of endogenous ␣1-ARs in WT adult cardiac myocytes.
Prazosin Induces ␣1-Adrenergic Receptors to Move off the Nuclear Membrane in Adult Mouse Cardiac Myocytes
In cultured WT adult cardiac myocytes, BODIPY-prazosin labeling also identified a small population of nonnuclear ␣1-ARs (Figure 1b ). We hypothesized that this was attributable to long-term incubation with BODIPY-prazosin, which induces ␤-arrestin-dependent receptor internalization (movement off the membrane). 21 To test this, we expressed the ␣1-GFP fusion proteins in cultured ␣1ABKO cardiac myocytes and examined the ␣1-subtype localization throughout a 16-hour treatment with unlabeled prazosin. Indeed, prazosin induced translocation of both the ␣1A-GFP and ␣1B-GFP off the nucleus, whereas vehicle treatment had no effect ( Figure 3 ). This effect was seen at 2 hours and was consistent throughout treatment for the ␣1A-GFP ( Figure 3 , time course). In summary, the nonnuclear ␣1-AR population observed with BODIPYprazosin staining is likely attributable to ␣1-AR translocation off the nuclear membrane, possibly by receptor desensitization, rather than a subpopulation of nonnuclear ␣1-ARs.
␣1-Adrenergic Receptors Localize to the Nucleus in Adult Mouse Cardiac Myocytes In Vivo
To determine whether the nuclear ␣1-AR localization we observed in cultured adult cardiac myocytes was similar in vivo, we generated cardiac-specific ␣1A-GFP transgenic mice and used an antibody against GFP to identify ␣1A-subtype localization in whole heart sections. Heart sections from the ␣1A-GFP transgenic mice stained for GFP, identified the ␣1A subtype at the nucleus (Figure 4 ), which parallels results from our culture model. Saturation binding analysis indicated that the ␣1A-GFP was overexpressed 7-fold in the heart (Figure Ia in the online data supplement). Functionally, ␣1A-GFP overexpression in- Figure 2 . The ␣1A and ␣1B subtypes colocalize with the nuclear membrane protein LAP2 in adult mouse cardiac myocytes. a, Cultured ␣1ABKO cardiac myocytes were infected with adenoviruses expressing the ␣1A-GFP (1000 multiplicities of infection) or ␣1B-GFP (3000 multiplicities of infection). After 40 hours, myocytes were fixed with 4% paraformaldehyde and stained with an antibody against the nuclear membrane marker LAP2 and a Texas red-conjugated secondary antibody. Fluorescent and transmitted light images were captured by confocal microscopy, and colocalization was determined using Imaris software. Final magnification, ϫ600. b, Cultured ␣1ABKO cardiac myocytes were infected as above and fractionated as in Figure 1 . Western blots were performed to detect the ␣1 subtypes using an antibody to GFP.
creased ␣1-mediated phosphorylation of ERK, as determined by Western blot (supplemental Figure Ib) . However, we did not detect a hypercontractile phenotype, as previously reported in ␣1A-Tg mice with 170-fold overexpression, nor did we detect a hypertrophic phenotype, as observed with overexpression of the ␣1B subtype (data not shown). 12, 22, 23 The ␣1A and ␣1B
Subtypes Colocalize With G␣q and PLC␤1 in the Nuclear Membrane in Adult Mouse Cardiac Myocytes
If functional ␣1-ARs are expressed on the nuclear membrane in adult cardiac myocytes, then the ␣1-signaling partners G␣q and PLC␤1 should colocalize to the nucleus as well. To test this, we used immunocytochemistry to determine whether G␣q and PLC␤1 were also expressed on the nuclear membrane. In cultured ␣1ABKO cardiac myocytes expressing ␣1A-GFP or ␣1B-GFP, we found that both G␣q and PLC␤1 localized to the nuclear membrane, as well as the plasma membrane (Figure 5a and 5b, respectively). However, image analysis revealed that both G␣q and PLC␤1 colocalized with the ␣1 subtypes only at the nuclear membrane.
To confirm the immunocytochemical analyses performed above, cellular fractionation and Western blot analyses were performed on freshly isolated WT adult mouse cardiac myocytes (Figure 5c ). Western blots for caveolin-3, GAPDH, and LAP2 validated the purity of the membrane, cytosolic, and nuclear fractions (Figure 5c ). Blotting the WT cell fractions for G␣q and PLC␤1 detected both signaling molecules in the nuclear fraction (Figure 5c ). In summary, G␣q and PLC␤1 colocalized with both ␣1-AR subtypes only in the nuclear membrane (defined by LAP2 staining), which supports the hypothesis that ␣1-ARs could signal at the nucleus in adult cardiac myocytes.
␣1-Adrenergic Receptors Do Not Localize to Caveolae in Adult Mouse Cardiac Myocytes
The colocalization of the ␣1-AR subtypes, G␣q, and PLC␤1 to the nuclear membrane suggests that ␣1-ARs signal from the nucleus not the plasma membrane. However, previous research suggested that ␣1-ARs localize to caveolae in rats 17 and adult mice. 12 Furthermore, others demonstrated that increasing caveolin-3 expression inhibits ␣1-ERK signaling in cardiac myocytes, whereas knocking out caveolin-3 leads to hyperactivation of ERK signaling. 14, 15 Here, we immunolabeled caveolin-3 to determine whether the ␣1-AR subtypes localized to caveolae. In cultured ␣1ABKO cardiac myocytes expressing the ␣1-GFP fusion proteins, caveolin-3 localized to the plasma membrane and t-tubules, whereas both ␣1-AR subtypes remained on the nucleus ( Figure 6 ). The failure to observe caveolin-3 colocalization with either ␣1-AR subtype provides evidence against a direct interaction of ␣1-ARs with caveolin-3 in adult cardiac myocytes. These results also suggest that the modulation of ␣1-AR signaling by caveolin-3 likely occurs with signaling molecules downstream of the receptor itself. . ␣1-ARs localize to the nucleus in adult mouse cardiac myocytes in vivo. Sagittal sections from hearts of ␣1A-GFP transgenic mice (␣1A-GFP Tg) or WT mice were stained with anti-GFP antibody (Santa Cruz Biotechnology) to detect ␣1A-GFP and visualized using the Mouse-on-Mouse Kit with an FITC-conjugated secondary antibody (Vector Laboratories). Final magnification, ϫ600.
Catecholamine Uptake and Activation of Nuclear
␣1-Adrenergic Receptors in Adult Mouse Cardiac Myocytes
To activate nuclear ␣1-ARs, norepinephrine or other catecholamines must enter the cardiac myocyte, a process known as norepinephrine-uptake-2, 24 which is facilitated by extraneuronal monoamine transporter (EMT/OCT3). 25 To measure catecholamine uptake in WT cardiac myocytes, we used a fluorescent catecholamine analog that fluoresces only when transported inside a cell. We found that catecholamine uptake occurred almost immediately, peaked at 30 minutes and was antagonized by addition of norepinephrine 15 minutes before catecholamine uptake measurement, indicating specificity (Figure 7a) .
To demonstrate the functionality of nuclear ␣1-ARs, we examined ␣1-AR mediated activation of ERK in cultured WT adult cardiac myocytes. Specifically, we compared the ability of CGP-12177A, a membrane impermeable ␣1-antagonist 26 -29 and prazosin, which freely crosses the plasma membrane, to block phenylephrine (PE) (␣1-agonist) induced phosphorylation of ERK in cultured WT adult cardiac myocytes. Prazosin blocked PE-mediated activation of ERK, whereas CGP-12177A did not (Figure 7b ), indicating that ␣1-AR mediated activation of ERK requires intracellular agonist and receptor.
In cultured WT adult cardiac myocytes, we detected EMT/OCT3 on both the plasma and nuclear membranes by immunocytochemistry (Figure 7c) . Furthermore, we demonstrated that inhibiting EMT/OCT3 with corticosterone, an EMT/OCT3 antagonist, prevented ␣1-mediated activation of ERK (Figure 7c ). Because our results indicate that ␣1-ARs, G␣q, and PLC␤1 localize to the nucleus, the results with CGP-12177A and corticosterone inhibition of EMT/OCT3 are best explained by ␣1 signaling at the nucleus.
Phosphorylated ERK Localizes to Caveolae at the Plasma Membrane in Adult Mouse Cardiac Myocytes
To investigate the mechanism of ␣1-mediated activation of ERK, we examined phosphorylated ERK localization following PE treatment. In cultured ␣1ABKO cardiac myocytes expressing ␣1A-GFP or ␣1B-GFP, PE led to phospho-ERK localization at the plasma membrane (Figure 8a ). The ␣1A-GFP was more efficacious than ␣1B-GFP in activating ERK (Figure 8b) , a difference we reported previously. 11, 30 Furthermore, in cardiac myocytes expressing the ␣1A-GFP, PE induced phospho-ERK plasma membrane localization within 5 minutes, which persisted for up to 3 hours (Figure 8c ). The localization of phospho-ERK to the plasma membrane was surprising, because the receptor and its signaling molecules were localized to the nuclear membrane. However, short-term PE treatment, which activated ERK at the plasma membrane, did not translocate ␣1-ARs from the nucleus, suggesting ␣1-AR signaling was initiated at the nucleus, with a postreceptor signal translocated to the plasma membrane.
To determine whether phosphorylated ERK localized to caveolae at the plasma membrane, we colocalized phospho-ERK and caveolin-3 following ␣1-AR stimulation in cultured ␣1ABKO cardiac myocytes expressing the ␣1A-GFP (Figure  8d) . Following PE treatment, phospho-ERK and caveolin-3 colocalized at the plasma membrane. To verify the caveolar Figure 5 . The ␣1A and ␣1B subtypes colocalize with G␣q and PLC␤1 in the nuclear membrane in adult mouse cardiac myocytes. ␣1ABKO cardiac myocytes were cultured, infected, and fixed as in Figure  2 and then stained with an antibody against G␣q (a) or PLC␤1 (b) and a Texas redconjugated secondary antibody, and confocal images were captured and prepared as in Figure 2 . Final magnification, ϫ600. c, Western blots were performed on WT cardiac myocyte cell fractions to detect G␣q and PLC␤1. Figure 6 . ␣1-ARs do not localize to caveolae in adult mouse cardiac myocytes. Cultured ␣1ABKO cardiac myocytes were infected as in Figure 2 , fixed with 4% paraformaldehyde, and stained with an antibody against caveolin-3 and an Alexa Fluor-594 -conjugated secondary antibody. Fluorescent and transmitted light images were captured by confocal microscopy and colocalization determined using Imaris software. Final magnification, ϫ600.
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localization of phospho-ERK, we disrupted the assembly of caveolae using filipin. 31 Increasing concentrations of filipin reduced the colocalization of phospho-ERK and caveolin-3, suggesting an interaction between phospho-ERK and caveolin-3 ( Figure 8d) . A putative caveolin-binding domain is present in ERK and previous research has shown an interaction between ERK and caveolins, 32-34 but we could not confirm a direct interaction between ERK and caveolin-3 by coimmunoprecipitation. However, our results demonstrating a loss of phospho-ERK and caveolin-3 colocalization following filipin treatment indicates that ERK likely localizes to caveolae, possibly via some intermediate binding partner. Furthermore, although ␣1-ARs do not localize to caveolae (Figure 6 ), ␣1-AR signaling could still be modified indirectly by caveolin-3 at the plasma membrane. 14, 15 In summary, our data suggest a novel model for ␣1-AR function in cardiac myocytes, where activation of nuclear ␣1-ARs leads to activated ERK localized to caveolae at the plasma membrane.
Discussion
Here, we examined the localization of both the ␣1A and ␣1B subtypes and the mechanisms regulating ␣1A-AR-ERK survival signaling in adult cardiac myocytes. Our data indicate that both the ␣1A and ␣1B subtypes localize to and signal at the nuclear membrane. Furthermore, our data suggest that ␣1-signal transduction from the nucleus to the plasma membrane results in activated ERK localization to caveolae in adult cardiac myocytes. The following lines of evidence support this novel paradigm for ␣1-AR signaling in cardiac myocytes. Using binding assays on subcellular fractions and a fluorescent ␣1 antagonist, we localized endogenous ␣1-ARs to the nucleus in WT adult cardiac myocytes, which was confirmed using ␣1-GFP fusion proteins in cultured ␣1ABKO cardiac myocytes and in vivo with ␣1-AR-GFP transgenic mice (Figures 1 through 4) . Furthermore, we colocalized the ␣1-signaling partners G␣q and PLC␤1 with both ␣1-AR subtypes in the nuclear membrane ( Figure 5 ), suggesting the possibility of ␣1 signaling at the nucleus. We failed to detect functional ␣1-ARs at the plasma membrane using confocal microscopy or functional studies examining ␣1-AR-mediated activation of ERK (Figures 6 and 7b) . However, activation of nuclear ␣1-ARs led to accumulation of activated (phosphorylated) ERK at the plasma membrane in adult cardiac myocytes, whereas the receptor remained at the nucleus (Figure 8a ). Finally, we demonstrated that phosphorylated ERK localizes to caveolae at the plasma membrane, which might provide a mechanism for caveolin-3 regulation of ␣1-AR signaling (Figure 8d) .
Previously, others hypothesized that ␣1-ARs are expressed in caveolae at the plasma membrane in cardiac myocytes. 16, 17, 35 These reports relied on isolation of caveolar membrane fractions, followed by immunoblots to detect ␣1-signaling partners and functional examination of inositol phosphate generation. However, some of these reports acknowledged the failure to identify ␣1-ARs in caveolae, possibly because of basic (pH 11) conditions used to isolate the caveolar membrane fractions. 16, 35 Alternatively, our data indicated that ␣1-ARs are expressed on the nuclear membrane in cardiac myocytes. The use of BODIPY-prazosin and ␣1-GFP fusion proteins in our reconstitution system avoided the technical challenges of isolating caveolar membrane fractions. Prior research also demonstrated that overexpression of caveolin-3 suppressed ␣1-AR signaling, 15 and caveolin-3 knockout increased activation of ERK. 14 In contrast to others, 12, 17 we demonstrated that these effects were probably not attributable to a direct interaction of ␣1-ARs and caveolin-3. However, our finding that activated ERK localized to caveolae following ␣1-AR stimulation provides a mechanism where caveolin-3 might regulate ␣1-AR signaling. Earlier studies in cardiac-specific ␣1A-AR transgenic mice suggested that ␣1-ARs are expressed on the plasma membrane in cardiac myocytes in vivo based on immunohistochemical detection of the ␣1A subtype in ventricular tissue sections. 12 However, we observed ␣1A localization to the nucleus in our ␣1A-GFP Tg mouse. This discrepancy might Figure 7 . Catecholamine uptake and activation of nuclear ␣1-ARs in adult mouse cardiac myocytes. a, Catecholamine uptake assay (Molecular Devices, Sunnyvale, Calif) was used to determine norepinephrine transport into WT cardiac myocytes. Specificity for norepinephrine uptake was confirmed by addition of norepinephrine (50 nmol/L or 10 mol/L) 15 minutes before catecholamine uptake measurement. The results represent triplicate measurements from 4 to 5 myocyte isolations. b, Cultured WT cardiac myocytes were treated with CGP-12177A (0 to 200 mol/L, membrane impermeable ␣1-AR antagonist) or prazosin for 15 minutes and then with PE (20 mol/L) for 15 minutes. Phospho-and total ERK levels were determined by Western blot. c, Cultured WT cardiac myocytes were harvested for Western blot detection of OCT3 or fixed with 4% paraformaldehyde and stained with an antibody against OCT3 (Santa Cruz Biotechnology) and an Alexa Fluor-594 -conjugated secondary antibody. Fluorescent images were captured by confocal microscopy. Final magnification, ϫ600. Cultured WT cardiac myocytes were treated with corticosterone (1 mol/L) for 15 minutes and then PE (20 mol/L) for 15 minutes. Phospho-and total ERK levels were determined by Western blot.
be attributable to the 170-fold level of overexpression examined in prior reports. 12 In summary, our results, both in vivo and in vitro, indicate that ␣1-ARs localize to the nuclear membrane in adult cardiac myocytes.
Nuclear localization of GPCRs in adult cardiac myocytes is not unique to ␣1-ARs. Functional endothelin-A and -B receptors and ␤-ARs, as well as their cognate signaling proteins, are also localized to the nuclear membrane of adult cardiac myocytes. 18, 19 Both of these reports directly demonstrated the functionality of their respective receptors on isolated nuclei, detecting a calcium transient in response to endothelin treatment 18 and cAMP accumulation in response to isoproterenol treatment. 19 Here, we localized ␣1-ARs, G␣q, and PLC␤1 to the nuclear membrane, and our experiments examining ␣1-mediated ERK activation indicate that ␣1-AR signaling was initiated at the nucleus in adult cardiac myocytes.
If ␣1-ARs localize to and activate signaling at the nucleus, then ␣1-agonists must enter the myocyte to initiate signaling. Norepinephrine entry into cardiac myocytes is facilitated by norepinephrine-uptake-2, 24 which is mediated by extraneuronal monoamine transporter (EMT/OCT3). 25 A previous report demonstrated that 3 H-norepinephrine is taken up by neonatal rat cardiac myocytes and accumulates in the nucleus. 36 We confirmed catecholamines are taken up in adult cardiac myocytes and detectable inside the cell within 5 minutes (Figure 7a) . In support of the results that demonstrate agonists like norepinephrine enter the myocyte to activate ␣1-ARs, we found that CGP-12177A, a membrane impermeable ␣1-AR antagonist, was unable to block PE-induced activation of ERK in cardiac myocytes, whereas prazosin did (Figure 7b) . Finally, we also identified EMT/OCT3 on both the plasma and nuclear membranes and confirmed its role in catecholamine uptake in adult cardiac myocytes (Figure 7c) .
In total, our data suggest a new model for ␣1-AR survival signaling. We propose that ligand enters the cardiac myocyte, binds to ␣1-ARs, and activates ␣1 signaling at the nucleus, which is transduced from the nucleus to the plasma membrane, causing activated ERK localization to caveolae and protection from cell death. This novel ␣1-signaling model does not fit the classic outside-in GPCR signaling model or the "caveolae signaling hypothesis" as described previously. 33 However, some details of this new model remain to be determined. First, the mechanism regulating ␣1-signal transduction from the nucleus to the plasma membrane is unknown but could involve protein kinase C, which is activated by ␣1-ARs, translocates to caveolae when activated, 37 and could lead to ERK phosphorylation. Second, potential downstream targets of ␣1-ERK signaling in cardiac myocytes are unidentified. Previous work in neonatal cardiac myocytes suggested that targets could include the survival/transcription factor GATA4 and the Bcl-2 family member Bad. 38, 39 However, we recently demonstrated that ␣1 signaling does not activate GATA4 and that GATA4 was not required for ␣1-mediated survival signaling in adult cardiac myocytes. 40 In summary, we found that the ␣1A and ␣1B subtypes localized to and activated signaling at the nuclear membrane Figure 8 . Phosphorylated ERK localizes to caveolae at the plasma membrane in adult mouse cardiac myocytes. a, Cultured ␣1ABKO cardiac myocytes were infected as in Figure 2 . After 40 hours, myocytes were treated with 20 mol/L PE for 15 minutes. Myocytes were fixed with 4% paraformaldehyde and stained with an antibody against P-ERK and a Texas red-conjugated secondary antibody. Fluorescent images were captured by confocal microscopy. Final magnification, ϫ600. b and c, The percentage of myocytes positive for P-ERK (nϭ100 to 124 myocytes per culture) was determined comparing ␣1A-GFP and ␣1B-GFP (nϭ3) (c) or the ␣1A-GFP time course (nϭ2) (d). Groups were compared by 1-way ANOVA with a Tukey's post test (PϽ0.05). d, Isolated ␣1ABKO cardiac myocytes were cultured and infected as above and then treated with filipin (5 to 10 g/mL) or vehicle for 1 hour followed by 20 mol/L PE for 15 minutes. Myocytes were fixed and stained with antibodies against P-ERK and caveolin-3, and images were captured by confocal microscopy and pseudocolored using Imaris software (GFP, pseudocolored magenta; P-ERK, green). Final magnification, ϫ600.
in adult cardiac myocytes. Activation of these nuclear ␣1-ARs led to accumulation of activated ERK at the plasma membrane, where caveolin-3 might regulate downstream ␣1-AR signaling. These results present a provocative new model for ␣1-AR signaling, where nuclear ␣1-ARs signal to the plasma membrane. This unique ␣1-AR-ERK survivalsignaling pathway challenges the classic model of ␣1-AR localization and signaling in adult cardiac myocytes.
SUPPLEMENTAL METHODS
Generation of adenoviral constructs
To generate α1A-GFP and α1B-GFP fusion proteins, cDNAs for the human α1A-AR (NM000680) and α1B-AR (NM000679) were amplified by polymerase chain reaction with primers designed to remove the stop codon and insert Bgl II and Mlu I restriction sites 5' and 3', respectively. The amplified α1A and α1B products were cloned into pCR2.1-TOPO (Invitrogen, Carlsbad, CA) and then subcloned into the Bgl II-Mlu I restriction sites in the multicloning site of the humanized pGFP 2 -N3 vector (BioSignal Packard, Montreal, Quebec, Canada), with GFP at the C-terminus. [1] [2] [3] [4] To generate adenoviruses expressing the α1A-GFP and α1B-GFP fusion proteins under control of the cytomegalovirus promoter, the α1A-AR-GFP 2 and α1B-AR-GFP 2 were amplified by polymerase chain reaction with primers designed to insert Pme I and Xba I restriction sites at the 5' and 3' ends, respectively. The amplified α1A-GFP and α1B-GFP products were cloned into the pCR2.1-TOPO vector (Invitrogen) and then subcloned into the Ventricular cardiac myocytes from adult male mice were cultured as previously described. [5] [6] [7] Briefly, hearts were removed, cannulated and perfused with collagenase type II (Worthington Biochemical Corp., Lakewood, NJ) to dissociate ventricular myocytes. Myocytes were plated at a density of 50 rod-shaped myocytes per square millimeter on laminin-coated culture dishes or coverslips. Myocytes were cultured in MEM with Hank's Balanced Salt Solution, 1 mg/ml bovine serum albumin, 10 mM 2,3-butanedione monoxime, and 100 U/ml penicillin in a 2% CO 2 incubator at 37°C. Following myocyte plating for 1 hr, the culture medium was changed and adenovirus was added.
Isolation of intact nuclei from adult mouse cardiac myocytes.
To isolate nuclei, we used procedures previously described to isolate 13, 14 Protease Inhibitor Cocktail). The nuclei and cell pellet from the total homogenate was resuspended in 500 µl of hypotonic lysis buffer, combined with 5.5 ml of 2.4 M sucrose and layered on top of 6 ml of a 2.4 M sucrose cushion and centrifuged at 100,000xg for 90 minutes to purify nuclei. The pelleted nuclei were resuspended in storage buffer and protein content determined for all fractions. The purity of the resulting protein fractions, cell membrane, cytosolic, and nuclear, was verified by Western blots using caveolin-3 (Santa Cruz; membrane marker), GAPDH (Research Diagnostics Inc, Concord, MA; cytosolic marker), and LAP2 (Cell Signaling; nuclear marker). All cell fractions were immunoblotted for Gαq, PLCβ1 (Santa Cruz), and GFP (marking α1A-or α1B-GFP; Santa Cruz).
Measurement of α1-AR expression.
α1-AR levels and binding affinity in cultured WT and α1ABKO myocytes expressing α1-ARs were measured by saturation binding with 
Analysis of extraneuronal monoamine transporter (EMT/OCT3) expression and function.
WT adult mouse cardiac myocytes were cultured in either 35 mm dishes or on laminin coated coverslips. After 40 hrs, cardiac myocytes were harvested for Western blot analysis of EMT/OCT3 expression or fixed with 4% paraformaldehyde and stained with primary antibody to EMT/OCT3 (Santa Cruz) and an Alexa Fluor-594-conjugated secondary antibody (Invitrogen) . EMT/OCT3 function was measured by using corticosterone, a specific EMT/OCT3 antagonist, to block α1-mediated activation of ERK. Cultured WT adult mouse cardiac myocytes were treated for 15 with 1 µM corticosterone and subsequently treated for 15 min with 20 µM phenylephrine. Phospho-and total ERK levels were measured by Western blot.
ONLINE FIGURE I
(a) α1-AR levels in WT and α1A-Tg cardiac myocytes were determined by saturation binding 
